跳至主要内容
临床试验/KCT0001895
KCT0001895已完成未知

Impact of ß-lactam therapy among patients with infections caused by extended-spectrum ß-lactamase-producing Enterobacteriaceae

Hallym University Medical Center-Kangnam0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • adult patients (= 19 years of age) presenting ESBL-E.coli urinary tract infection

排除标准

  • presence of suspicious or confirmatory infectious foci other than urinary tract infection, any use of antibiotics within seven days prior to recruitment for any reasons, any complicating urinary factors which could not be effectively treated during trial (obstruction, suspected or confirmed prostatitis, epididymitis), indwelling urinary catheters expected to remain in place after therapy has been completed and need for renal replacement therapy.

研究者

发起方
Hallym University Medical Center-Kangnam

相似试验